[HTML][HTML] Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated …
Brugada syndrome (BrS) is an inherited arrhythmogenic disease that may lead to sudden
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With …
V Di Mauro, P Ceriotti, F Lodola, N Salvarani… - FRONTIERS IN …, 2021 - iris.unipv.it
Brugada syndrome (BrS) is an inherited arrhythmogenic disease that may lead to sudden
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With …
V Di Mauro, P Ceriotti, F Lodola, N Salvarani… - FRONTIERS IN …, 2021 - boa.unimib.it
Brugada syndrome (BrS) is an inherited arrhythmogenic disease that may lead to sudden
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With …
V Di Mauro, P Ceriotti, F Lodola, N Salvarani… - Frontiers in …, 2020 - europepmc.org
Brugada syndrome (BrS) is an inherited arrhythmogenic disease that may lead to sudden
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With …
V Di Mauro, P Ceriotti, F Lodola… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Brugada syndrome (BrS) is an inherited arrhythmogenic disease that may lead to sudden
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
[HTML][HTML] Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated …
V Di Mauro, P Ceriotti, F Lodola, N Salvarani… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Brugada syndrome (BrS) is an inherited arrhythmogenic disease that may lead to sudden
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With …
V Di Mauro, P Ceriotti, F Lodola, N Salvarani… - Frontiers in …, 2021 - europepmc.org
Brugada syndrome (BrS) is an inherited arrhythmogenic disease that may lead to sudden
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …
cardiac death in young adults with structurally normal hearts. No pharmacological therapy is …